| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |